Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Drugs
- Pharmaceuticals
- Disease
- Therapeutic
- Biotechnology
- Diagnostic
- Diagnostic Substances
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 28926
1) UCLA CASE NO. 2015-280 “Using Estrogens as Treatment to Improve Fatigue in Multiple Sclerosis and Other Neurodegenerative Diseasesâ€
Provisional Patent Application No. 62/067,264 entitled, “Compositions and Methods for Treating Fatigueâ€, filed October 22, 2014 (UCLA Case No. 2015-280-1) by Dr. Rhonda R. Voskuhl, and assigned to The Regents.
2) UCLA CASE NO. 2015-282 “Using Estrogens as Treatments to Improve Depression Mood in Multiple Sclerosis and Other Neurodegenerative Diseasesâ€
Provisional Patent Application No. 62/068,162 entitled, “Compositions and Methods for Treating Depressionâ€, filed October 24, 2014 (UCLA Case No. 2015-282-1) by Dr. Rhonda R. Voskuhl, and assigned to The Regents.
3) UCLA CASE NO. 2015-605 “Estriol Blood Level for Maximizing Treatment in MSâ€
Provisional Patent Application No. 62/140,239 entitled, “Methods of Monitoring Estriol Therapyâ€, filed October 30, 2014 (UCLA Case No. 2015-605-1) by Dr. Rhonda R. Voskuhl, and assigned to The Regents.
4) UCLA CASE NO. 2015-606-1 “Sparing Gray Matter Atrophy In Ms Patients That Are Enhancing Lesion Negativeâ€
Provisional Patent Application No. 62/140,245 entitled, “Methods of Providing Neuroprotective Therapyâ€, filed March 30, 2015 (UCLA Case No. 2015-606-1) by Dr. Rhonda R. Voskuhl, and assigned to The Regents.
IPSCIO Record ID: 890
The Regents also grant to Licensee the right to issue exclusive or nonexclusive subLicenses to third parties.
U.S. Patent Application No. 10/131,384 entitled Estriol Therapy for Multiple Sclerosis and Other Autoimmune Diseases, filed April 24, 2002, which was based on Provisional Application No. 60/286,842 filed 4/25/01 (UCLA Case Nos 1998-531-1,2) by Dr. Voskuhl, and assigned to The Regents.
U.S. Patent Application No. 10/984,364 entitled The Use of Estrial and Other Estranes, Estrogen and Estrogen Receptor Active Compositions in the Treatment of Psoriasis…, filed November 8, 2004, (UCLA Case No. 2004-101-3) by Drs. Rhonda R. Voskuhl, Gerald D. Weinstein and Jenny E. Murase and assigned to The Regents.
IPSCIO Record ID: 4655
2. “ Humanin and Humanin Analogues to treat T1DM†(UCLA Case No. 2007-714)(Issued US Patent 7,998,928 and U.S. Patent Application 13/180,181);
3. “SHLPs†(UCLA Case No. 2008-488)(U.S. Patent Application 12/989,688); and
4. “Humanin and analogues for atherosclerosis†(UCLA Case No. 2011-331)(U.S. Provisional Patent Application 61/498,474).
Licensed Product means any article, composition, apparatus, substance, chemical, or any other material covered by a Valid Claim within The University’s Patent Rights or whose manufacture, import use, offer for sale, or sale would, absent the license granted under this Agreement, constitute an infringement, inducement of infringement or contributory infringement of any Valid Claim within The University's Patent Rights, or any service, article, composition, apparatus, chemical, substance or any other material made, used or sold by or utilizing or practicing a Licensed Method. If the Licensed Product is a component of another product such as a kit, composition of matter or combination, such kit, composition of matter or combination is deemed to be the Licensed Product for purposes of this Agreement.
T2DM is Type 2 Diabetes Mellitus which is a chronic metabolic disease that affects the body’s ability to turn food into energy. Normally, after eating, sugar in the form of glucose from the food enters the bloodstream. The hormone Insulin, released from the pancreas in response to the rising levels of glucose in the bloodstream, is responsible for transporting the glucose into the body’s cells, to be used as fuel.
T1DM is Type 1 Diabetes Mellitus which is a chronic illness characterized by the body’s inability to produce insulin due to the autoimmune destruction of the beta cells in the pancreas. Onset most often occurs in childhood, but the disease can also develop in adults in their late 30s and early 40s.
Atherosclerosis is a disease in which plaque (plak) builds up inside your arteries. Arteries are blood vessels that carry oxygen-rich blood to your heart and other parts of your body. Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. Over time, plaque hardens and narrows your arteries. This limits the flow of oxygen-rich blood to your organs and other parts of your body. Atherosclerosis can lead to serious problems, including heart attack,stroke or even death.
IPSCIO Record ID: 29338
The University granted to Licensee an exclusive License under The University’ interest in Provisional Patent Application No. 61/030,316 entitled Screening Test for Gestational Diabetes Mellitus filed 02/21/2008 (UCLA Case No. 2007-523-1) (University Patent Rights) in jurisdictions where Regents' Patent Rights exist, to make, have made, use, sell, offer for sale and import Licensed Products (as Licensed Products is defined in the ELA) and to practice Licensed Methods (as Licensed Methods is defined in the ELA) in all fields of use to the extent permitted by law.
Gestational diabetes (or gestational diabetes mellitus, GDM) is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy (especially during third trimester of pregnancy).
IPSCIO Record ID: 26212
